o On September 22-24, 2014, IIR staff facilitated contributions to the BJA-supported Harold Rogers Prescription Drug Monitoring Program (PDMP) National Meeting, held in Washington, DC. While the Chairman of the GSSWG PDMP Task Team was the on-site attendee and presenter (his participation supported by Global), staff also contributed significantly by providing logistical planning support and substantive assistance: one of the highlights of Global’s PDMP presentation was a preview of the soon-to-be released Call to Action and Issue Brief: Justice System Use of Prescription Drug Monitoring Programs: Addressing the Nation’s Prescription Drug and Opioid Abuse Epidemic. IIR supported all aspects of deliverable development, including initial planning conference calls, literature review and research, content submission, editing and formatting, and shepherding of the review process.
Please check the box next to the following questions if the answer is 'yes'.
Please enter the applicable Event Date if there is an Event associated with this TTA.
When entering an Event Date, the Time is also required.
If the TTA is targeted to a particular audience or location, please complete the questions below.
Milestones are an element, activity, work product, or key task associated with completing the TTA (e.g. kick-off meeting, collect data from stake holders, deliver initial data analysis).
Please complete the fields below, if applicable, to create a milestone for this TTA.
Please respond to the Performance Metrics below. The Performance Metrics questions are based on the TTA Type indicated in the General Information section of the TTA.
Please submit a signed letter of support from your agency’s executive or other senior staff member. The letter can be emailed to or uploaded with this request. The letter should be submitted on official letterhead and include the following information:
- General information regarding the request for TTA services, i.e., the who, what, where, when, and why.
- The organizational and/or community needs specific to the request for TTA services.
- The benefits or anticipated outcomes from the receipt of TTA services.
By submitting this application to BJA NTTAC, I understand that upon approval of this application for TTA, the requestor agrees to keep BJA NTTAC informed of any circumstances that may impact the delivery of the TTA, including changes in the date of the event, event cancellation, or difficulties communicating with the assigned TTA provider.
Please call [site:phone] if you need further assistance completing this application.